Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis.

Cytokine & growth factor reviews - 1 Aug 1996

Beauparlant P, Hiscott J

Abstract excerpt

The NF-kappa B/Rel family of transcription factors participates in the activation of a diverse range of genes involved in inflammation, immune response, lymphoid differentiation, growth control and development. The present review provides a brief overview of NF-kappa B/Rel activation and a detail...

Topics

Animals
Antioxidants
Aspirin
Cyclosporine
Cytokines
Dinoprostone
Forecasting
Glucocorticoids
Humans
Immunosuppressive Agents
Mutation
NF-kappa B
Nitric Oxide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Oncogene Proteins v-rel

Phosphorylation

Protease Inhibitors

Proto-Oncogene Proteins

Retroviridae Proteins, Oncogenic

Source

Identifiers

PMID: 8899295
DOI: 10.1016/1359-6101(96)00020-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8899295-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis.PMID 8899295Read ↗

NF-&#954;B in Human Disease: Current Inhibitors and Prospects for De Novo Structure Based Design of InhibitorsSemantic proximity Read ↗

NF-κB: a key role in inflammatory diseasesSemantic proximity Read ↗

Targeting NF-κB: A Promising Molecular Therapy in Inflammatory ArthritisSemantic proximity Read ↗

Exploring the positive and negative consequences of NF-kappaB inhibition for the treatment of human disease.Semantic proximity Read ↗

THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsSemantic proximity Read ↗

Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)Semantic proximity Read ↗

Nuclear Factor-κB: a Key Regulator in Health and Disease of LungsSemantic proximity Read ↗

Small Molecule NF-κB Pathway Inhibitors in ClinicSemantic proximity Read ↗

New Insights into the Role of Nuclear Factor-κB, a Ubiquitous Transcription Factor in the Initiation of DiseasesSemantic proximity Read ↗

NF-&#954; B and Rheumatic DiseasesSemantic proximity Read ↗

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancerSemantic proximity Read ↗

Transcription Factor NF-κB: An Update on Intervention StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.